<DOC>
	<DOCNO>NCT00283556</DOCNO>
	<brief_summary>The purpose study compare response treatment side effect associate high dose irinotecan patient recurrent brain tumor .</brief_summary>
	<brief_title>High Dose Camptothecin-11 ( CPT-11 ) Recurrent Unresectable Malignant Glioma</brief_title>
	<detailed_description>This phase I/II study high dose irinotecan patient recurrent unresectable malignant glioma steroids/anti-epileptics . The purpose compare response treatment side effect associate high dose irinotecan patient recurrent brain tumor .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>recurrent , unresectable primary CNS neoplasm per MRI ECOG status 2 less prior therapy camptothecans enzymeinducing antiepileptic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>High Dose Irinotecan</keyword>
	<keyword>CPT-11</keyword>
	<keyword>Camptosar</keyword>
	<keyword>Malignant Glioma</keyword>
	<keyword>Unresectable</keyword>
</DOC>